Yeliu Wang

Title: **Yeliu Wang: Innovator in Pharmaceutical Chemistry**

Introduction

Yeliu Wang is a distinguished inventor based in Beijing, China. With a focus on pharmaceutical chemistry, he has made significant contributions to the field through his innovative work. His groundbreaking research has led to the development of therapeutic compounds that aim to address pressing health concerns.

Latest Patents

Yeliu Wang holds a patent for the invention titled "Iminosulfanone compound as bromodomain protein inhibitor and pharmaceutical composition and medical use thereof." This patent describes an iminosulfanone compound, which acts as a bromodomain protein inhibitor, along with a pharmaceutically acceptable salt, its preparation method, pharmaceutical composition, and potential medical uses. This work showcases his expertise in creating novel compounds that can have substantial applications in medicine.

Career Highlights

Throughout his career, Yeliu Wang has been associated with reputable companies, including Chia Tai Tianqing Pharmaceutical Group Co., Ltd. and Shouyao Holdings (Beijing) Co., Ltd. His roles in these organizations allowed him to apply his knowledge in pharmaceutical development and production, contributing to advancements in drug discovery and formulation.

Collaborations

Yeliu has collaborated with noteworthy professionals in his field, including Jijun Li and Yan Zhu. These collaborations have enabled him to bolster his research and development efforts, leading to innovative solutions in pharmaceutical science.

Conclusion

In conclusion, Yeliu Wang stands out as a prominent inventor in the pharmaceutical industry. His patent on iminosulfanone compounds exemplifies his dedication to advancing medical science. Through his career and collaborations, he continues to pave the way for innovative treatments and therapies that could benefit patients globally.